コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 lex (TSC) genes TSC1 (hamartin) and/or TSC2 (tuberin).
2 he tuberous sclerosis complex 2 gene product tuberin.
3 via Rheb is an mTOR-independent function of tuberin.
4 t the evolutionarily conserved C terminus of tuberin.
5 codes for hamartin, or TSC2, which codes for tuberin.
6 ntaining the RING zinc finger motif binds to tuberin.
7 apping 14-3-3 and Akt recognition site(s) in tuberin.
8 he interaction between endogenous 14-3-3 and tuberin.
9 uct of the tuberous sclerosis-2 (TSC2) gene, tuberin.
10 t was not important for the interaction with tuberin.
11 growth suppressing functions of hamartin and tuberin.
12 6, the X-linked retinoschisis gene and TSC2/tuberin.
13 is likely dependent on its interaction with tuberin.
14 and analyze pathological point mutations in tuberin.
15 xpression, paralleling its effect on Akt and tuberin.
16 he tuberous sclerosis complex 2 gene product tuberin.
17 ange in phosphorylation of either Akt/PKB or tuberin.
18 alized within the carboxyl 73 amino acids of tuberin.
20 findings demonstrate for the first time that tuberin activates Rho and regulates cell adhesion and mi
24 of either TSC genes (TSC1, hamartin or TSC2, tuberin), an event that is implicated in the induction o
25 milar decrease in the activation of AMPK and tuberin and activation of mTOR with increase in Nox4 and
26 vated Ras also induce the phosphorylation of tuberin and collaborates with the nutrient-sensing pathw
27 ose leads to phosphorylation/inactivation of tuberin and downregulation of OGG1 via a redox-dependent
28 a protein expression through inactivation of tuberin and downstream activation of ribosomal protein S
30 An in vivo association between full-length tuberin and ERalpha was observed in HEK 293 cells and EL
32 ant increases in the basal levels of phospho-tuberin and fibronectin expression in the kidney cortex.
39 es that underlie tuberous sclerosis complex, tuberin and hamartin, lie at the center of an important
40 erin complexes, promoting phosphorylation of tuberin and increased degradation of hamartin-tuberin co
41 PTE cells to HG increased phosphorylation of tuberin and p70S6K, phosphorylation of Bcl-2, expression
42 ated with mitogen-induced phosphorylation of tuberin and recognition of tuberin by an alpha-Akt phosp
43 conclusion that REDD1 functions upstream of Tuberin and Rheb to down-regulate mTOR signaling in resp
44 ox) inhibit Akt-dependent phosphorylation of tuberin and stabilizes tuberin protein levels in VHL-def
45 e results suggested that hamartin stabilizes tuberin and this contributes to the inhibition of cell g
46 he tumor suppressor TSC1 (hamartin) or TSC2 (tuberin) and increased angiogenesis, fibrosis, and abund
48 t the cytoplasmic tail of PC1 interacts with tuberin, and the mTOR pathway is inappropriately activat
49 ta, epsilon, tau, eta, and sigma) could bind tuberin, and this interaction was abrogated by competiti
50 on of TSC1 increased the endogenous level of tuberin, and transient co-transfection of TSC1 with TSC2
51 man NTera2 neurons (NT2N) transfected with a tuberin antisense construct that reduced tuberin express
56 r functions of TSC2 and its protein product, tuberin, are not known, somatic mutations in the TSC2 tu
60 was found to interact with and phosphorylate tuberin at a regulatory site, Ser-1798, located at the e
61 omozygous for the del3 allele express mutant tuberin at low levels, and show enhanced activation of m
63 C/MAPK signaling leads to phosphorylation of tuberin at sites that overlap with and are distinct from
64 hamartin colocalizes with hypophosphorylated tuberin at the membrane, where tuberin exerts its GTPase
65 reflected by differential phosphorylation of tuberin at threonine 1462 and serine 1798, respectively,
69 Ectopic expression of hamartin and wild-type tuberin, but not mutant tuberin, reduced beta-catenin st
70 as repressed by coexpression of hamartin and tuberin, but the activity of rapamycin-resistant mutants
74 hosphorylation of tuberin and recognition of tuberin by an alpha-Akt phosphorylation substrate antibo
78 substrate of Akt and that phosphorylation of tuberin by PI3K/Akt is a major mechanism controlling ham
80 nslational inactivation of the TSC2 protein, tuberin, by physiologically inappropriate phosphorylatio
83 t phosphorylated hamartin and phosphorylated tuberin co-immunoprecipitate with the mitotic kinase Plk
85 In cultured cortical neurons, hamartin and tuberin co-localize with neurofilament light chain prefe
86 a novel interaction partner for the hamartin/tuberin complex and implicate hamartin and mTOR in the r
87 artin regulates the function of the hamartin-tuberin complex during the G2/M phase of the cell cycle.
89 n and it is possible to recover the hamartin-tuberin complex over the neurofilament light chain rod d
90 or some of the CNS functions of the hamartin-tuberin complex, and abolishing this through mutations i
93 strate that Akt/PKB associates with hamartin-tuberin complexes, promoting phosphorylation of tuberin
95 ddress these issues a series of hamartin and tuberin constructs were used to assay for interaction in
98 esize that Pam, through its interaction with tuberin, could regulate the ubiquitination and proteasom
99 Short interfering RNA down-regulation of tuberin decreased the p42/44 MAPK phosphorylation and B-
100 associated with enhanced phosphorylation of tuberin, decreased OGG1 protein expression, and 8-oxodG
101 mass was significantly greater in partially tuberin-deficient (TSC2(+/-) ) diabetic rats than wild-t
105 , we expressed a dominant negative allele of tuberin (DeltaRG) behind the cytomegalovirus promoter in
108 mbryos lacking functional Tsc2 gene product, tuberin, displayed dysraphia and papillary overgrowth of
109 the neuroepithelium, indicating that loss of tuberin disrupted the normal development of this tissue.
110 whereby the inactivating phosphorylation of tuberin downstream of phosphatidylinositol (PI) 3-kinase
112 Normal cellular functions of hamartin and tuberin, encoded by the TSC1 and TSC2 tumor suppressor g
114 ort the hypothesis that interactions between tuberin, ERalpha, and CaM may play a critical role in th
116 hosphorylated tuberin at the membrane, where tuberin exerts its GTPase-activating protein (GAP) activ
117 Tuberin interacts with phosphohamartin, and tuberin expression attenuates the phosphorylation of exo
132 erexpression of Rheb, a downstream target of Tuberin function and a positive upstream effector of mTO
133 by Disheveled, suggesting that hamartin and tuberin function at the level of the beta-catenin degrad
134 ssion of MCP-1 seems to be caused by loss of tuberin function because Eker rat embryonic fibroblasts
137 eb-mediated S6K1 activation, suggesting that Tuberin functions as a Rheb GTPase activating protein (G
138 genetic evidence for individual hamartin and tuberin functions that may explain some of the genotype-
139 hamartin (N198_F199delinsI;593-595delACT) or tuberin (G294E and I365del), abolished or dramatically r
140 Supporting this notion, TSC patient-derived Tuberin GAP domain mutants were unable to inactivate Rhe
142 of each and every interacting partner of the tuberin-hamartin complex could potentially alter the dis
148 ar binding partner hamartin, suggesting that tuberin-hamartin interactions negatively impact the abil
150 uced assembly of the mTOR regulatory complex Tuberin.Hamartin is disrupted in L6 myoblasts following
151 nhibits the tumor suppressor function of the tuberin/hamartin complex, resulting in increased mTOR si
153 We found that TS model cells derived from tuberin heterozygous mice and from a human renal angiomy
154 f diabetes also increased phosphorylation of tuberin in association with mTOR activation (measured by
156 beta and ERK-1/-2 suggest a pivotal role for tuberin in directing the signaling events that dictate t
157 lel with this observation, the expression of tuberin in ELT-3 cells also resulted in significant inhi
161 Thus, expression of a dominant negative tuberin in multiple tissues can lead to a tissue-specifi
164 e Rho, we stably expressed full-length human tuberin in two cell types: MDCK cells and ELT3 cells.
166 and subsequent tuberous sclerosis complex 2/tuberin inactivation or by suppression of AMP-activated
167 patient-derived cell line (bearing biallelic Tuberin inactivation), we demonstrate that E2 stimulates
168 he target of the GTPase-activating domain of tuberin, inhibited wild-type B-Raf kinase but not activa
171 emonstrate that the amino-terminal region of tuberin interacts specifically with the MH2 domain of SM
176 independent studies have shown that loss of tuberin is associated with elevated AMPK signaling and a
177 ylation, and 3) defective phosphorylation of tuberin is associated with loss of its tumor suppressor
178 mals, suggest that the loss or inhibition of tuberin is associated with up-regulation of cyclin D1.
179 bilization was explained by the finding that tuberin is highly ubiquitinated in cells, while the frac
181 Our data show for the first time that 1) tuberin is phosphorylated at tyrosine and serine residue
183 Upon insulin or growth factor stimulation, tuberin is phosphorylated by several kinases, including
184 e demonstrate that, upon activation of PI3K, tuberin is phosphorylated on consensus recognition sites
190 rtin but has a deletion in the C terminus of tuberin, leading to constitutive activation of rap1 and
196 locus mutations were confirmed and the mean tuberin mRNA expression levels was reduced across all ni
203 tment rapidly reduced levels of hamartin and tuberin, negative regulators of mTOR, in a calpain-depen
206 tive and rapamycin-insensitive mechanisms of tuberin-null cell growth, likely via Rheb and Rho inhibi
207 In addition, forced expression of tuberin in tuberin-null cells abolished the expression of fibronect
208 lung colonization of intravenously injected tuberin-null cells by 3-fold, which is blocked by treatm
209 e of women associated with the metastasis of tuberin-null cells with hyperactive mammalian target of
214 indicating that binding between ERalpha and tuberin occurs at the C-terminal end of the tuberin mole
216 e 3-kinase (PI3K)/Akt pathway phosphorylates tuberin on Ser-939 and Thr-1462 that inhibits the tumor
217 strated that SGK1 induces phosphorylation of tuberin, p70s6kinase, and GSK3beta in CMs, which may con
223 t significantly reduced high glucose-induced tuberin phosphorylation and restored OGG1 expression.
224 ed ROS generation, Akt/protein kinase B, and tuberin phosphorylation and resulted in deceased 8-oxodG
226 ificant decrease in AMPK phosphorylation and tuberin phosphorylation on its AMPK-dependent activating
227 ated TSC2 mutation (Y1571H) nearly abolished tuberin phosphorylation when stimulated with pervanadate
228 es, 2) TSC1-TSC2 interaction is regulated by tuberin phosphorylation, and 3) defective phosphorylatio
229 nal cell carcinoma correlates with increased tuberin phosphorylation, decreased tuberin protein level
230 Inhibition of mTOR had no effect on AMPK or tuberin phosphorylation, indicating that mTOR is downstr
233 Taken together, these data suggest that tuberin plays a central role in the development of renal
234 nt phosphorylation of tuberin and stabilizes tuberin protein levels in VHL-deficient renal carcinoma
235 increased tuberin phosphorylation, decreased tuberin protein levels, and increased phosphorylation of
236 ree non-pathogenic missense polymorphisms of tuberin (R261W, M286V, R367Q) in the same region as the
239 martin and wild-type tuberin, but not mutant tuberin, reduced beta-catenin steady-state levels and it
242 , TSC1 and TSC2, which code for hamartin and tuberin respectively, play central roles in regulating c
243 TSC1 and TSC2 (also known as hamartin and tuberin, respectively) form a functional complex and neg
244 teins encoded by TSC1 and TSC2, hamartin and tuberin, respectively, associate with each other forming
246 of TSC1 and TSC2, also known as hamartin and tuberin, respectively, form a physical and functional co
247 and TSC2 proteins, also called hamartin and tuberin, respectively, have been shown to regulate cell
248 cts of the TSC1 and TSC2 genes, hamartin and tuberin, respectively, heterodimerize and inhibit the ma
254 lerosis complex 2 (TSC2) gene, which encodes tuberin, result in the development of TSC and lymphangio
255 f-BRAF-driven NSC proliferation results from tuberin/Rheb-mediated mammalian target of rapamycin (mTO
256 the identification of Rheb as the target of tuberin's (TSC2) GTPase activating protein (GAP) domain.
257 e-activating protein Tuberin, which inhibits Tuberin's ability to inactivate the small GTPase Rheb.
258 wo observations fostered the hypothesis that tuberin's impact on estrogen-mediated signaling might be
259 ere found to be modulated by the presence of tuberin's predominant intracellular binding partner hama
263 biquitinated in cells, while the fraction of tuberin that is bound to hamartin is not ubiquitinated.
272 s cell growth, and hamartin is known to bind tuberin, these results suggested that hamartin stabilize
273 dent on Wnt stimulation such that binding of tuberin to GSK3 and Axin was reduced in the presence of
275 nteractions negatively impact the ability of tuberin to modulate ERalpha-mediated gene transcription
276 nsic GAP activity toward Rheb but partitions tuberin to the cytosol, where it is bound by 14-3-3 prot
277 enhanced in cells lacking expression of the tuberin (TSC2(-/-)) or hamartin (TSC1(-/-)) genes, consi
278 SC2, whose gene products hamartin (TSC1) and tuberin (TSC2) constitute a putative tumor suppressor co
282 ase primarily affecting young women in which tuberin (TSC2)-null cells metastasize to the lungs.
283 reatment alone in inhibiting the survival of tuberin (TSC2)-null cells, growth of TSC2-null xenograft
286 e cells, we show that ELT-3 cells expressing tuberin (TSC2+/+) respond to platelet-derived growth fac
288 ation with ERalpha and the C-terminal end of tuberin was also observed in vivo and in vitro, indicati
289 eover, except for a subset of kidney tumors, tuberin was expressed in both human and mouse tumors.
292 y curtailed the growth inhibitory effects of tuberin when overexpressed in COS1 cells, consistent wit
295 is complex 2 (TSC2) gene encodes the protein tuberin, which functions as a key negative regulator of
296 phorylation of the GTPase-activating protein Tuberin, which inhibits Tuberin's ability to inactivate
297 factor (IGF) 1 stimulates phosphorylation of tuberin, which is inhibited by the phosphatidylinositol
298 tigated the effect of the signaling molecule tuberin, which modulates the mammalian target of rapamyc
299 hamartin interacts with Plk1 independent of tuberin with all three proteins present in a complex.
300 ide the first structural information on TSC2/tuberin with novel insight into the molecular function.
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。